NeuroMetrix, Inc.

General ticker "NURO" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $8.2M (TTM average)

NeuroMetrix, Inc. follows the US Stock Market performance with the rate: 13.7%.

Estimated limits based on current volatility of 0.4%: low 4.57$, high 4.60$

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.89$, 7.84$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.60$, 4.78$]

Financial Metrics affecting the NURO estimates:

  • Negative: Non-GAAP EPS, $ of -4.06 <= 0.04
  • Negative: negative Operating income
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -47.30 <= 1.79
  • Negative: negative Industry operating income (median)
  • Negative: Shareholder equity ratio, % of 93.39 > 63.75
  • Negative: Industry operating cash flow per share per price (median), % of -3.23 <= 2.82

Similar symbols

Short-term NURO quotes

Long-term NURO plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $8.26MM $5.90MM $3.03MM
Operating Expenses $13.00MM $13.05MM $11.81MM
Operating Income $-4.74MM $-7.15MM $-8.78MM
Non-Operating Income $0.33MM $0.62MM $0.98MM
R&D Expense $3.24MM $2.78MM $1.79MM
Income(Loss) $-4.42MM $-6.53MM $-7.81MM
Profit(Loss)* $-4.37MM $-6.53MM $-7.81MM
Stockholders Equity $23.36MM $20.09MM $14.31MM
Inventory $1.61MM $1.56MM $1.35MM
Assets $24.67MM $21.42MM $15.32MM
Operating Cash Flow $-5.29MM $-6.08MM $-7.13MM
Capital expenditure $0.02MM $0.18MM $0.00MM
Investing Cash Flow $-16.81MM $1.16MM $5.35MM
Financing Cash Flow $3.86MM $2.33MM $1.48MM
Earnings Per Share** $-4.90 $-6.27 $-3.96

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.